STADA
Pharmaceutical group selling generics, specialty medicines and consumer healthcare.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- STADA Arzneimittel AG
- Entity type
- COMPANY
- Headquarters
- Stadastraße 2-18, 61118 Bad Vilbel
- Company size
- >5,000
- Market role
- Advertiser / Brand
- Official website
- stada.com
What STADA does
STADA operates a scaled pharmaceutical manufacturing and brand commercialisation model. It creates value by developing, manufacturing and distributing medicine and healthcare portfolios across generics, specialty pharmaceuticals and consumer health products, then monetises those products through B2B sales into healthcare and retail channels at volume.
Category differentiation
STADA is a pharmaceutical and consumer healthcare manufacturer, not an adtech, martech or software platform. It sells medicines and healthcare products rather than media, data or SaaS tools.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
STADA Arzneimittel AG is a Germany-headquartered pharmaceutical and consumer healthcare company. It develops, manufactures and sells consumer healthcare products, generic medicines and specialty pharmaceuticals through a global operating footprint. Following CapVest Partners LLP's majority acquisition on 31 March 2026, STADA remains an active standalone operating group under private ownership. The company generates revenue primarily from the sale of pharmaceutical and healthcare products through healthcare distribution and retail channels. Its paying customers are pharmacies, wholesalers, hospitals, healthcare providers, retailers and distribution partners, with end-consumer demand supporting parts of the consumer healthcare portfolio. STADA's scale is evidenced by 2025 group sales of €4,296 million and 11,670 employees worldwide.
Business model & monetisation
STADA monetises through product sales of generics, specialty pharmaceuticals and consumer healthcare goods. Revenue is generated primarily via wholesale and institutional distribution, pharmacy and retail sell-in, and broader branded healthcare product sales rather than software subscriptions or advertising.
- Generic pharmaceuticals sales
- One-time Sale
- Consumer healthcare product sales
- Retail Margin
- Specialty pharmaceuticals sales
- One-time Sale
Products & capabilities
No products with linked sources are available in this view.
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
Huth+Wenzel wins Stada's Elotrans Reload account
Agency & Consultancy · Recorded impact score: 2/5
Frankfurt-based agency Huth+Wenzel has won the creative account for Stada's Elotrans Reload. The first joint campaign is running immediately through mid-October across social media, Connected TV, linear TV (channels like RTL Zwei), digital out-of-home and ambient placements. The account move ends the prior cooperation with Schmittgall Health, which had handled the brand since the product launch in 2023. The campaign centers on a humorous fictional character named "Stefan" and the agency says it used artificial intelligence as a creative tool to develop Out-of-Home motifs. Claudia Rodrigues (Brand Manager at Stada) and Andreas Liehr (Huth+Wenzel managing director) are quoted on the campaign approach.
- Huth+Wenzel won the creative pitch for Elotrans Reload, a brand of Stada.
- The first Huth+Wenzel campaign for Elotrans Reload runs now until mid-October across social media, Connected TV, linear TV (e.g., RTL Zwei), DOOH and ambient formats.
Explore company relationships
Questions about STADA
What is STADA?
STADA is a Germany-headquartered pharmaceutical group that develops, manufactures and sells consumer healthcare products, generics and specialty pharmaceuticals.
Who uses STADA?
STADA's products are bought by pharmacies, wholesalers, hospitals, healthcare providers, distributors and retail partners, with many products ultimately used by patients and consumers.
How does STADA make money?
STADA makes money by selling pharmaceutical and consumer healthcare products through healthcare, wholesale and retail distribution channels.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
8 publicly documented primary sources and citations linked across the market graph.
Continue your research on STADA
Explorer includes additional company details, a Watchlist for up to 25 companies and your personal Strategic Intelligence Agent. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.
Free, with no time limit.